Literature DB >> 27927707

Pancytopenia associated with levetiracetam in an epileptic woman.

Rafael García Carretero1, Marta Romero Brugera2, Monica Olid-Velilla3, Inmaculada Salamanca-Ramirez3.   

Abstract

Haematological toxicity due to antiepileptic drugs is uncommon, but the increased risk of aplastic anaemia has been reported. Few case reports have been published regarding pancytopenia associated with levetiracetam treatment, and its intrinsic pathogenesis is still unknown. We describe the case of a woman aged 77 years who presented with abdominal pain and loss of appetite. She had been taking valproic acid, due to a previous episode of epileptic seizures, and presented with drowsiness and dizziness. Valproate was discontinued and therapy with levetiracetam was initiated. 2 days later, we observed severe anaemia, leucopenia and thrombocytopenia, which were attributed to levetiracetam. Although she recovered soon after the treatment was discontinued, it took 2 weeks for cell counts to return to normal. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27927707      PMCID: PMC5174826          DOI: 10.1136/bcr-2016-217407

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Levetiracetam-induced thrombocytopenia.

Authors:  Elin Kimland; Bo Höjeberg; Mia von Euler
Journal:  Epilepsia       Date:  2004-07       Impact factor: 5.864

2.  Pancytopenia associated with levetiracetam treatment in Lafora's disease.

Authors:  Harun Aydoğan; Saban Yalçn; Mahmut Alp Karahan; Evren Büyükfrat
Journal:  Blood Coagul Fibrinolysis       Date:  2012-03       Impact factor: 1.276

3.  A case of levetiracetam-induced thrombocytopenia.

Authors:  Roger Oghlakian; Charles Nock; Mohamad Koubeissi
Journal:  Epileptic Disord       Date:  2010-11-16       Impact factor: 1.819

4.  Levetiracetam-induced pancytopenia.

Authors:  Bouraoui Elouni; Chaker Ben Salem; Michel Biour
Journal:  Ann Pharmacother       Date:  2009-05       Impact factor: 3.154

5.  Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study.

Authors:  Kinshuk Sahaya; Munish K Goyal; Aarti Sarwal; Niranjan N Singh
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Thrombocytopenia during levetiracetam therapy.

Authors:  A Meschede; U Runge; M Sabolek
Journal:  Epilepsy Res       Date:  2008-07       Impact factor: 3.045

8.  Pancytopenia associated with levetiracetam treatment.

Authors:  Massimo Gallerani; Elisa Mari; Benedetta Boari; Rossella Carletti; Anna Marra; Michele Cavallo
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Saima Kayani; Deepa Sirsi
Journal:  J Cent Nerv Syst Dis       Date:  2012-03-08

10.  Levetiracetam-induced pancytopenia.

Authors:  Talal Alzahrani; Dana Kay; Saeed A Alqahtani; Yamane Makke; Linda Lesky; Mohamad Z Koubeissi
Journal:  Epilepsy Behav Case Rep       Date:  2015-07-24
  10 in total
  1 in total

1.  Delayed Recognition of Levetiracetam-induced Pancytopenia.

Authors:  Mohammad Ammad Ud Din; Syed Ather Hussain; Amy Bodrog
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.